Healthcare provider profile · identity verified

Michelle Ann Kane, MD

Internal Medicine · SAINT LOUIS, MO · NPI 1659480689

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	792	202
Atorvastatin Calcium	Atorvastatin Calcium	672	181
Amlodipine Besylate	Amlodipine Besylate	632	172
Rosuvastatin Calcium	Rosuvastatin Calcium	628	165
Losartan Potassium	Losartan Potassium	621	163
Alprazolam	Alprazolam	261	66
Pantoprazole Sodium	Pantoprazole Sodium	246	76
Hydrochlorothiazide	Hydrochlorothiazide	242	67
Lisinopril	Lisinopril	234	65
Omeprazole	Omeprazole	228	66
Gabapentin	Gabapentin	223	57
Escitalopram Oxalate	Escitalopram Oxalate	212	58
Tramadol Hcl	Tramadol Hcl	192	37
Metoprolol Succinate	Metoprolol Succinate	191	56
Famotidine	Famotidine	143	38
Furosemide	Furosemide	142	47
Metformin Hcl	Metformin Hcl	138	41
Duloxetine Hcl	Duloxetine Hcl	134	31
Metoprolol Tartrate	Metoprolol Tartrate	132	39
Metformin Hcl Er	Metformin Hcl	129	35
Trazodone Hcl	Trazodone Hcl	127	35
Montelukast Sodium	Montelukast Sodium	125	33
Potassium Chloride	Potassium Chloride	119	35
Ibandronate Sodium	Ibandronate Sodium	114	31
Synthroid	Levothyroxine Sodium	114	30
Albuterol Sulfate Hfa	Albuterol Sulfate	106	48
Simvastatin	Simvastatin	103	33
Atenolol	Atenolol	97	23
Sertraline Hcl	Sertraline Hcl	94	27
Allopurinol	Allopurinol	92	23
Zolpidem Tartrate	Zolpidem Tartrate	89	22
Ezetimibe	Ezetimibe	84	30
Spironolactone	Spironolactone	82	20
Carvedilol	Carvedilol	81	22
Citalopram Hbr	Citalopram Hydrobromide	81	20
Irbesartan	Irbesartan	80	17
Eliquis	Apixaban	79	26
Triamcinolone Acetonide	Triamcinolone Acetonide	76	25
Fluoxetine Hcl	Fluoxetine Hcl	74	21
Mirtazapine	Mirtazapine	73	19
Ozempic	Semaglutide	71	14
Venlafaxine Hcl Er	Venlafaxine Hcl	71	16
Buspirone Hcl	Buspirone Hcl	70	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	21
Pravastatin Sodium	Pravastatin Sodium	69	20
Meloxicam	Meloxicam	68	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	66	18
Glimepiride	Glimepiride	64	18
Temazepam	Temazepam	64	13
Trulicity	Dulaglutide	62	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	59	59
Clopidogrel	Clopidogrel Bisulfate	58	17
Liothyronine Sodium	Liothyronine Sodium	57	15
Vitamin D2	Ergocalciferol (Vitamin D2)	55	19
Ondansetron Odt	Ondansetron	54	20
Hydralazine Hcl	Hydralazine Hcl	53	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	13
Lorazepam	Lorazepam	52	14
Valacyclovir	Valacyclovir Hcl	51	24
Tizanidine Hcl	Tizanidine Hcl	50	21
Warfarin Sodium	Warfarin Sodium	49	11
Bupropion Xl	Bupropion Hcl	48	16
Estradiol	Estradiol	48	14
Fluticasone Propionate	Fluticasone Propionate	48	18
Glipizide Er	Glipizide	48	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	13
Doxazosin Mesylate	Doxazosin Mesylate	47	15
Fenofibrate	Fenofibrate	47	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	46	39
Tamsulosin Hcl	Tamsulosin Hcl	43	13
Cefdinir	Cefdinir	42	38
Tradjenta	Linagliptin	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	19
Prednisone	Prednisone	39	25
Diclofenac Sodium	Diclofenac Sodium	38	12
Finasteride	Finasteride	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Diazepam	Diazepam	34	suppressed
Azithromycin	Azithromycin	33	28
Dicyclomine Hcl	Dicyclomine Hcl	33	11
Januvia	Sitagliptin Phosphate	32	suppressed
Jardiance	Empagliflozin	32	11
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Ramipril	Ramipril	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Dilt-Xr	Diltiazem Hcl	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Clobetasol Propionate	Clobetasol Propionate	30	14
Nystatin	Nystatin	30	11
Pregabalin	Pregabalin	30	suppressed
Amoxicillin	Amoxicillin	29	14
Farxiga	Dapagliflozin Propanediol	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Azelastine Hcl	Azelastine Hcl	28	11
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Risedronate Sodium	Risedronate Sodium	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	12
Acyclovir	Acyclovir	23	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	23	suppressed
Valsartan	Valsartan	23	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Methocarbamol	Methocarbamol	21	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Torsemide	Torsemide	21	suppressed
Bupropion Hcl	Bupropion Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Glipizide	Glipizide	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	14
Eszopiclone	Eszopiclone	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Baclofen	Baclofen	14	suppressed
Glyxambi	Empagliflozin/Linagliptin	14	suppressed
Nyamyc	Nystatin	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Vivelle-Dot	Estradiol	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Topiramate	Topiramate	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Lidocaine	Lidocaine	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Naloxone Hcl	Naloxone Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Tranexamic Acid	Tranexamic Acid	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error